Dextall | $15,000,000 | (Jul 15, 2025)
Duranta | $7,000,000 | (Jul 15, 2025)
Circuit(US) | $4,500,000 | (Jul 15, 2025)
Corvia Medical, Inc.
United States
- Tewksbury, MA
- 18/06/2025
- Unknown
- $55,000,000
Corvia Medical, Inc. is revolutionizing the treatment of heart failure with a novel transcatheter structural heart device. Founded in 2009 and headquartered in Tewksbury, MA, Corvia Medical is dedicated to transforming the standard of care for heart failure treatment, enabling patients to reclaim their lives. The Corvia® Atrial Shunt is the world’s first transcatheter device approved by the European Union to treat heart failure with preserved (HFpEF) or mid-range (HFmrEF) ejection fraction.
Privately held, the company is backed by Third Rock Ventures, General Catalyst Partners, AccelMed, and Lumira Ventures, Edward Lifesciences and an undisclosed strategic investor. In the United States, the Corvia Atrial Shunt System is an investigational device and not available for commercial distribution or sale.
- Industry Medical Equipment Manufacturing
- Website https://us.corviamedical.com/home/
- LinkedIn https://www.linkedin.com/company/corvia-medical/
ScienceMachine | $3,500,000 | (Jul 15, 2025)
Bastazo | $5,300,000 | (Jul 15, 2025)
Asepha | $4,000,000 | (Jul 15, 2025)
Moonvalley | $84,000,000 | (Jul 15, 2025)
MOTOR Ai | $20,000,000 | (Jul 15, 2025)
RealSense | $50,000,000 | (Jul 15, 2025)
Live Story | $3,154,279 | (Jul 11, 2025)
Spacelift | $51,000,000 | (Jul 11, 2025)
Cerebrium | $8,500,000 | (Jul 11, 2025)